Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
about
Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.High mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV.HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study.Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners' perspectives before and after community reentryEmergency department use among HIV-infected released jail detainees.Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention.The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model.Challenges in managing HIV in people who use drugsThe Influence of Medication Attitudes on Utilization of Antiretroviral Therapy (ART) in Indonesian PrisonsInfluence of Jail Incarceration and Homelessness Patterns on Engagement in HIV Care and HIV Viral Suppression among New York City Adults Living with HIV/AIDS.HIV treatment and care among Italian inmates: a one-month point survey.Efficacy of a Process Improvement Intervention on Inmate Awareness of HIV Services: A Multi-Site Trial.Routine or targeted HIV screening of Indonesian prisoners.Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.Effect of social relationships on antiretroviral medication adherence for people living with HIV and substance use disorders and transitioning from prison.An exploratory study of therapeutic misconception among incarcerated clinical trial participants.HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study."Inside These Fences Is Our Own Little World": Prison-Based HIV Testing and HIV-Related Stigma Among Incarcerated Men and Women.Understanding interactions of formerly incarcerated HIV-positive men and transgender women with substance use treatment, medical, and criminal justice systems.Exploring HIV Risk and Ex-Offender Status Among African American Church Populations: Considerations for Faith-Based Settings.The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis.Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.HIV outcomes at a Canadian remand centre.Incarceration History and Uncontrolled Blood Pressure in a Multi-Site Cohort.Outcomes of on-site antiretroviral therapy provision in a South African correctional facility.Patient navigators effectively support HIV-infected individuals returning to the community from jail settings.Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study.Long Acting Injectable Anti-Retroviral Therapy: An Opportunity to Improve HIV Treatment and Reduce HIV Transmission among Persons being Released from Prison Facilities.Assessment of HIV Knowledge in Correctional Facility Health Care Workers: A Pilot Study of an Educational Intervention.Effectiveness of Single- and Multiple-Tablet Antiretroviral Regimens in Correctional Setting for Treatment-Experienced HIV Patients.Predictors of Mortality within Prison and after Release among Persons Living with HIV in Indonesia.Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study.Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.Sex-Related Disparities in Criminal Justice and HIV Treatment Outcomes: A Retrospective Cohort Study of HIV-Infected Inmates.Risk behaviors and HIV care continuum outcomes among criminal justice-involved HIV-infected transgender women and cisgender men: Data from the Seek, Test, Treat, and Retain Harmonization Initiative.Effectiveness of a Peer Navigation Intervention to Sustain Viral Suppression Among HIV-Positive Men and Transgender Women Released From Jail: The LINK LA Randomized Clinical Trial.Jail Booking as an Occasion for HIV Care Reengagement: A Surveillance-Based Study.
P2860
Q30248944-4D869C87-4462-4B3B-A91B-684B1B17A51CQ33614946-04CE931C-60CD-4216-8F0D-2A4D3DB090A8Q34598681-02CDD90F-54F1-4B87-9D3A-62E837B4AD33Q34817072-3FC40DB7-8008-431B-9D50-653797DBEB37Q34967941-0743C474-27DB-4384-AA6C-464165260EF2Q35112855-3C8EDF81-47B7-486F-9F01-B2225438FA7EQ35194961-461C1A14-1C69-4FA2-A7AE-EE0DE7294A39Q35532871-D8A0E92A-5FCA-4B0E-B2E9-474CB2D96C0BQ35538674-468E343B-4E23-4595-B47F-7141D8B3E0DDQ35785892-6A41FED1-D2DA-4891-972A-7027A0C37347Q35850471-89018614-F46F-49F2-898D-F6045ABFC842Q35865208-4F39C0B9-D790-45DE-8218-8EE8E3F77AF2Q35867157-0FC8B13C-79EB-4A37-B70E-90AC4A22CB11Q35942752-0D2F0DCC-6BE5-4294-AC87-DD9DC63A43ADQ36362007-A22A9B60-229A-4B11-8A1A-5AC0F4E1384CQ36385539-5715C224-C934-4545-BEFC-87A5264E1717Q36394808-56F4E35E-0E88-48D1-9658-68016F3CD131Q36463626-481BDEA0-99BE-456B-8BDC-CC453DFED30AQ37136056-8D763AC3-71FC-4BB1-A241-097C3F8B22E5Q38627005-F42B99E6-5C1B-4575-BA4E-5674147A168FQ38737752-4219D4F1-C8CF-4804-918E-E9E92A1D9AD5Q38829492-5E0B7024-F313-4529-BCBE-4FAD35DA8929Q38882435-168BD8D7-A2F6-43C1-82BF-4B812AE21F37Q38933752-87264E1D-7BA4-491F-8EF2-5B23B7FB458FQ39399374-B076FB30-CAFE-481C-8A53-CA21548F9BDEQ39516374-7E9EEEFD-0C32-4560-B767-09D93C8F963CQ40044269-3A8BB4F4-B231-41F8-809A-522AA9C8A3FAQ40092676-E73CF361-4379-43CC-9E58-690F25D8695BQ40197333-1C2F6AE8-93F3-4E5C-AE01-3D8DE8CF48C7Q41028204-A3876848-5B04-4673-AE5F-C61011999B67Q46732158-E361D8AE-2C1C-486E-9FC0-9EE17E1FDE16Q47159420-139E41AF-0FD7-49C2-992F-3406BF846CAAQ47389289-381127A5-6A11-4C63-AA02-D05078636DA4Q47548700-308E5F2E-9F49-49FC-B7B8-A1F9836AFE42Q53423564-4976D7A1-869E-4F4F-9B58-39F6BF11DF19Q54202940-D9479FEC-B81D-41D7-8B5B-371DC20916F9Q54257188-121F556C-93C5-4784-A4BD-00CFFCEBA23EQ54510992-2B515701-D30B-4962-9D94-C4CE224BCAA8
P2860
Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Optimization of human immunode ...... uppression at the prison gate.
@ast
Optimization of human immunode ...... uppression at the prison gate.
@en
type
label
Optimization of human immunode ...... uppression at the prison gate.
@ast
Optimization of human immunode ...... uppression at the prison gate.
@en
prefLabel
Optimization of human immunode ...... uppression at the prison gate.
@ast
Optimization of human immunode ...... uppression at the prison gate.
@en
P2093
P2860
P50
P1476
Optimization of human immunode ...... uppression at the prison gate.
@en
P2093
Javier Cepeda
Robert L Trestman
P2860
P304
P356
10.1001/JAMAINTERNMED.2014.601
P577
2014-05-01T00:00:00Z